Activity Title: Virtual Symposium: Combining GLP-1RAs with Insulin to Improve Glucose Control
Activity Format: Virtual Symposium
Program Description:
Combining GLP-1RAs with basal insulin provides complementary action, lowering both PPG and FPG, to improve glycemic control in T2DM. The weight-sparing effect of GLP-1RAs makes them well suited for use in patients with concerns about insulin-induced weight gain. This activity will discuss the use of insulin and GLP-1RA combinations to achieve glycemic control and potentially reduce cardiometabolic risk.
Estimated Time to Complete: 1.5 hours
Release Date: December 19, 2016
Expiration Date: December 19, 2017
Credit Type(s) Available: ACCME, CDR, ANCC
Maximum Credits: 1.5 AMA PRA Category 1 Credit(s)™
Provided By: This activity is jointly provided by Medical Education Resources, Inc (MER) and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.
Commercial Supporter:
Supported by an educational grant from Sanofi US.
Purpose Statement:
To improve patient outcomes through early identification and intervention strategies for patients with, or at risk of developing, diabetes and cardiovascular disease.
Intended Audience:
This activity is designed for advanced-level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- DESCRIBE the clinical inertia that exists in T2DM as it relates to insulin therapy.
- SUMMARIZE the clinical rationale and evidence for combining GLP-1 receptor agonists with basal insulin so as to address various underlying pathophysiologic components of type 2 diabetes.
- ANALYZE the findings of recent clinical trials examining the use of basal insulin therapy in combination with GLP-1RAs for the management of patients with T2DM.
- COMPARE the safety, efficacy, and pharmacological data on available and emerging basal insulin analogs in patients with diabetes.
- PROPOSE safe and effective treatment plans to achieve PPG control in patients who are not at goal using basal insulin.
Faculty Information:
Jay S. Skyler, MD
- Professor of Medicine, Pediatrics, & Psychology
- Division of Endocrinology, Diabetes & Metabolism
- University of Miami Miller School of Medicine
- Deputy Director for Clinical & Academic Programs
- Diabetes Research Institute
- Miami, FL
Grants/Research Support: Mesoblast, Viacyte
Consulting Fees: AstraZeneca, Boehringer Ingelheim/Eli Lilly Collaboration, Dance Biopharm, Debiopharm, DexCom, Inc., DiaVacs, Elcelyx Therapeutics, Elizabeth Therapeutics, Gilead, Intarcia Therapeutics, Merck, Moerae Matrix, Orgenesis, Paean Therapeutics, Regeneron, Sanofi Diabetes, SynAlpha, VasoPrep Surgical, Viacyte, vTv Therapeutics (Trans Tech)
Robert H. Eckel, MD
- Professor of Medicine
- Division of Endocrinology, Metabolism and Diabetes
- Division of Cardiology
- Professor of Physiology and Biophysics
- Charles A. Boettcher II Chair in Atherosclerosis
- Director, T32 in Obesity and Cardiovascular Disease
- University of Colorado Anschutz Medical Campus
- Director, Lipid Clinic, University Hospital
- Aurora, CO
Consulting Fees: Sanofi-aventis, Regeneron, Janssen
Robert E. Ratner, MD
- Chief Scientific and Medical Officer
- American Diabetes Association
- Alexandria, VA
Disclosures: Dr. Ratner has nothing to disclose.
Julio Rosenstock, MD
- Director, Dallas Diabetes and Endocrine Center
- Clinical Professor of Medicine
- University of Texas Southwestern Medical Center
- Dallas, TX
Grants/Research Support: Merck, Pfizer, Sanofi, Novo Nordisk, Roche, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Takeda, AstraZeneca, Janssen, Daiichi Sankyo, Lexicon, Boehringer-Ingelheim, and Intarcia
Consulting Fees: Roche, Sanofi, Novo Nordisk, Eli Lilly, Daiichi Sankyo, AstraZeneca, Janssen, Boehringer-Ingelheim, Lexicon, and Intarcia
Disclosure of Conflicts of Interest:
It is the policy of MER to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.
Provider Disclosures:
The following content managers reported no financial relationships with commercial interests whose products or services may be mentioned in this CME/CE activity:
MER: Julie Johnson, PharmD, Veronda Smith, FNP
CMHC: Erin Franceschini, MS, Mary Mihalovic, Karin McAdams
Accreditation
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources and Tarsus Cardio Inc. dba Cardiometabolic Health Congress. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.
Medical Education Resources designates each enduring material for a maximum of 1.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Each CE activity provides 1.5 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hour.
Dietician Credit
Medical Education Resources (Provider Number ME110) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEUs) for completion of each program/material.
(CDR Activity Number: 130795)
Disclaimer:
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, CMHC and/or the various industry supporters. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, CMHC, and/or the various industry supporters. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Instructions for CME/CE Credit:
Participants are expected to answer all delivered questions before attempting to complete the post-test and evaluation for that activity. Successful completion will lead to the issuance of a certificate for 1.5 AMA PRA Category 1 Credit(s)™.
To receive credit, the course must be completed on or before December 19, 2017.
There are no fees for participating in and receiving CME credit for this activity. In order to claim CME credit for this activity registration is required prior to viewing the activity.
During the period December 19, 2016 through December 19, 2017, participants must follow these steps in order to receive CME/CE credit:
- Sign In or Register at https://www.cardiometabolichealth.org/my-account.html
- Read and accept the Terms & Conditions including the learning objectives and faculty disclosures.
- Complete the pre-test by recording the best answer to each question in the answer key. There is no scoring of the pre-test questions section.
- Review the educational activity.
- Complete the post-test by recording the best answer to each question in the answer key. Successful completion of the post-test is required to earn CME/CE credit. Successful completion is defined as a cumulative score of at least 70%.
- Complete the online evaluation form.
- After successfully completing the post-test and online evaluation form, your CME/CE certificate will be generated and will be available immediately for print.
Hardware and Software Requirements:
This online activity must be viewed with the latest version of Chrome, Firefox or Internet Explorer. If you do not have these browsers, you can download Chrome here, Firefox here and Internet Explorer here. Optimal viewing requires a broadband connection of at least 3 Mbps and a 1 GHz processor with 1 GB RAM.
Policy on Privacy and Confidentiality:
(MER) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MER and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting to the appropriate accrediting agency. To view the MER privacy policy, please click here. MER and CMHC maintain physical, electronic, and procedural safeguards that comply with federal regulations to guard your non-public personal information.
MER can be contacted by e-mail at data@mer.org or by telephone at 303-798-9682.
